Stick with value stocks until everyone is talking about them — and they are still under the radar, this Wall Street firm says.

Bank of America’s BofA Securities reiterates a preference for large-cap value stocks, arguing they are “stubbornly under the radar” and can provide “ballast” for investors. The call suggests “stealth-strength” value names have yet to gain broad attention as an ongoing positioning opportunity, rather than a specific earnings/guidance catalyst.

Analysis

The important mechanism here is positioning, not fundamentals: large-cap value still works best when it is not crowded, because the rerating comes from incremental buyer demand rather than a dramatic earnings inflection. That favors liquid financials and cash-generative industrials with visible capital return, where even modest multiple expansion can add 10-15% upside without heroic profit assumptions. BAC is the cleanest large-cap proxy for that setup, but the trade only persists if the market keeps paying for lower-duration cash flows and does not re-accelerate the growth/AI complex.

Second-order, if the value factor broadens, the next winners are not necessarily the biggest names; they are the neglected, balance-sheet-clean small caps that can move on low volume as allocators search for “hidden quality.” That is where names like CRMT can become very violent: cheap can mean mispriced, but it can also mean structurally impaired liquidity and weak sponsorship, so the upside is asymmetric only if fundamentals stabilize. In other words, broad value leadership helps the factor, but not every cheap stock participates equally.

The main risk is a quick rate rally or a benign macro print that revives long-duration growth leadership; in that case value loses its defensive bid and the relative trade can unwind in days. Over 1-3 months, the real catalyst is earnings breadth: if banks, cyclicals, and value ETFs keep beating on modest revisions, the market will have to chase the factor even without a narrative shift. Over 6-18 months, the thesis breaks if recession odds rise materially, because “ballast” becomes code for earnings compression rather than stability.

Key Decisions for Investors

• Long BAC / short QQQ for 1-3 months: express the view that unloved value can still outperform if rates stay sticky and breadth stays broad; target a 2:1 reward-to-risk with the pair sized to neutralize market beta.
• Buy IVE or RPV versus IWF on any growth-led strength over the next 2-4 weeks: this is a cleaner factor trade than single-name risk, and it should work if institutional flow keeps favoring under-owned value.
• Do not force CRMT as a core long; keep it on a watchlist only. If liquidity improves and the company prints two consecutive quarters of gross-margin stability, the stock could rerate sharply, but the downside from a value trap is just as large.
• Set a risk alert on a sharp decline in long-end yields or a renewed QQQ leadership breakout: that would be the clearest falsifier for the value-under-the-radar thesis and should trigger de-risking of BAC/XLF longs.